Feature | Artificial Intelligence | July 07, 2020 | By Sanjay Parekh, Ph.D.

Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers

Artificial intelligence platforms and marketplaces, akin to mobile app stores, offer a unified approach to deploying AI in medical imaging

As the nascent market for artificial intelligence (AI) in medical imaging develops, healthcare providers are faced with the question of how best to select, purchase and implement the rapidly expanding range of regulatory approved AI-enabled imaging applications and AI algorithms. 

More than 50 vendors have received regulatory clearance for medical imaging AI products and with more than 200 algorithm developers active in the market, product availability will increase many-fold in the coming years. Purchasing algorithms direct from multiple vendors adds an administrative overhead, not to mention the technical challenges of integrating these algorithms in existing systems and clinical workflows. AI platforms and marketplaces, akin to mobile app stores, offer a unified approach to deploying AI in medical imaging. A summary of the advantages and disadvantages for healthcare providers of AI marketplaces is provided in Figure 1.

 

The first marketplace/platform offerings entered the market in the last couple of years, and several new ones were announced at the 2019 annual meeting of the Radiological Society of North America (RSNA 2019). The performance and functionality of these solutions varies between vendors, with some offering what is essentially an online application store, with little or no support for integration, and others offering end-to-end solutions that address many of the engineering (deployment, workflow integration, etc.) and commercial (contracting, billing, etc.) challenges associated with the distribution and implementation of AI.

Selecting a Vendor

Some of the criteria that healthcare providers should consider when selecting a marketplace/platform vendor includes partnerships, applications, regulatory clearance, workflow, functionality, deployment, contracting and support. This selection guide is based on verified contributions from each of the vendors. Signify Research market data analysts anticipate this will be a useful resource for healthcare providers when determining whether to implement a marketplace offering, and then, which vendor to select. You can view the complete flowchart at https://bit.ly/2TR7RC8.

AI marketplaces with the most partners and greatest number of applications and algorithms may, at first sight, appear the obvious to partner with. However, healthcare providers are advised to consider how these will be implemented in clinical practice, and the level of contracting and technical support provided by the marketplace. The selection guide (see above link) also covers a range of other criteria and functionalities that should be considered, and how today’s marketplaces perform against these criteria. For example, when considering workflow integration, providers are advised to consider:

• How images are routed to the AI;

•How algorithms/applications are prioritized;

•How the radiologist engages with the AI results; and

•How the results are populated in the radiologist report. 

 

Other considerations include deployment options and tools for clinicians to develop their own AI solutions.

 

Sanjay M Parekh, Ph.D., is a senior market analyst at Signify Research Ltd. His current research focuses on the artificial intelligence and machine learning in medical imaging market. Signify Research is an independent supplier of market intelligence and consultancy to the global healthcare technology industry. Its major coverage areas include healthcare IT, medical imaging, and digital health. Clients include technology vendors, healthcare providers and payers, management consultants and investors. The company is headquartered at Cranfield, U.K.

Related Content

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in 
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
Clearing medical device cybersecurity requirements from DoD delivers even more safety assurance for customers
News | Cybersecurity | July 23, 2020
July 23, 2020 — Carestream Health’s ImageView software has received the Risk Management Framework Authority to Operat
News | Artificial Intelligence | July 14, 2020
July 14, 2020 — Lunit, a leading medical AI startup, announced the expansion of its collaboration with...
News | Information Technology | July 14, 2020
July 14, 2020 — The COVID-19 pandemic caused hea
Infervision's newly FDA approved CT lung AI application sets a new standard
News | Artificial Intelligence | July 10, 2020
July 10, 2020 — Infervision announced U.S.
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Several drivers will contribute to the growth of the teleradiology market in terms of penetration, revenue and read volumes over the next five years

Getty Images

Feature | Teleradiology | July 08, 2020 | By Arun Gill
Last year was a record year for the global...